Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image

New

Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Report
181 Pages
April 2025
Region: Global
TechSci Research
ID: 5915661

The Pharmaceutical Gelatin Market was valued at USD 1.89 Billion in 2024, and is expected to reach USD 2.61 Billion by 2030, rising at a CAGR of 5.51%. Pharmaceutical gelatin is a critical excipient widely used in drug formulations such as capsules, tablets, and hemostats due to its biocompatibility and ability to meet stringent safety and purity standards.

Derived primarily from animal collagen, pharmaceutical gelatin undergoes rigorous processing, including sterilization and purification, to ensure it is free from pathogens, allergens, and harmful substances. Its consistent performance in enhancing drug stability, bioavailability, and patient compliance makes it indispensable across various therapeutic applications. Regional preferences and regulatory guidelines often dictate the source of gelatin - whether bovine, porcine, fish, or poultry. The growing demand for oral dosage forms, coupled with technological advances in pharmaceutical manufacturing, continues to propel market expansion globally.

Key Market Drivers

Growing Pharmaceutical Industry

The expanding pharmaceutical sector is a primary driver of the pharmaceutical gelatin market, with increasing demand for effective and patient-friendly dosage forms such as capsules. Gelatin plays a vital role in improving drug solubility, enabling controlled drug release, and enhancing the overall stability of active pharmaceutical ingredients (APIs). Regulatory bodies like the FDA and EMA recognize gelatin as a safe and effective excipient when manufactured under strict quality controls and Good Manufacturing Practices (GMP). This endorsement strengthens its widespread use in both conventional and advanced drug delivery systems. As pharmaceutical innovation continues to grow, particularly in personalized medicine and complex therapies, gelatin’s functional versatility is expected to further solidify its market position.

Key Market Challenges

Raw Material Supply and Price Volatility

The pharmaceutical gelatin market faces notable challenges due to the reliance on animal-derived raw materials such as bovine and porcine collagen. Factors like disease outbreaks (e.g., African swine fever), climate events, and fluctuating livestock populations can disrupt supply chains and elevate production costs. Environmental concerns, ethical considerations, and rising interest in alternative materials also add complexity to sourcing decisions. Additionally, raw material costs are sensitive to variables such as feed prices, transportation, and currency fluctuations, leading to inconsistent pricing. Meeting stringent regulatory requirements for pharmaceutical-grade gelatin adds further layers of cost and operational effort. These dynamics collectively pose risks to production stability and profitability, particularly for manufacturers operating in price-sensitive markets.

Key Market Trends

Shift Towards Plant-Based Alternatives

The rising demand for sustainable, cruelty-free, and allergen-friendly products is driving interest in plant-based alternatives to animal-derived pharmaceutical gelatin. These alternatives cater to growing vegan and vegetarian populations and meet religious or cultural dietary restrictions. They also present a more environmentally sustainable option, often requiring fewer natural resources and generating lower greenhouse gas emissions.

Recent advancements in food and material science have enabled the development of plant-based gelling agents that mimic the functional properties of traditional gelatin. As pharmaceutical companies seek to diversify their excipient sources, plant-based gelatin substitutes are gaining attention for their potential to meet both functional and ethical criteria. However, achieving comparable performance and regulatory approval remains a focus of ongoing innovation.

Key Market Players

Gelita AG
Trobas Pharmaceutical gelatine B.V
Rousselot SAS
Gelatines Weishardt SAS
Sterling Biotec Ltd.
Catalent, Inc
Nitta Pharmaceutical Gelatin India Limited
Aspire Pharmaceuticals
Gelco International
Lapi Gelatine S.p.a

Report Scope:

In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Pharmaceutical Gelatin Market, By Type:

Type A
Type B

Pharmaceutical Gelatin Market, By Source:

Porcine
Bovine Skin
Bovine Bone
Fish
Poultry

Pharmaceutical Gelatin Market, By Function:

Stabilizing
Thickening
Gelling
Others

Pharmaceutical Gelatin Market, By End User:

Hard Capsule
Soft Capsule
Tablet
Absorbable Hemostat
Others

Pharmaceutical Gelatin Market, By Region:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Gelatin Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pharmaceutical Gelatin Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Type A, Type B)
5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map

6. North America Pharmaceutical Gelatin Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Source
6.2.3. By Function
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmaceutical Gelatin Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Source
6.3.1.2.3. By Function
6.3.1.2.4. By End User
6.3.2. Mexico Pharmaceutical Gelatin Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Source
6.3.2.2.3. By Function
6.3.2.2.4. By End User
6.3.3. Canada Pharmaceutical Gelatin Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Source
6.3.3.2.3. By Function
6.3.3.2.4. By End User

7. Europe Pharmaceutical Gelatin Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Source
7.2.3. By Function
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Pharmaceutical Gelatin Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Source
7.3.1.2.3. By Function
7.3.1.2.4. By End User
7.3.2. Germany Pharmaceutical Gelatin Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Source
7.3.2.2.3. By Function
7.3.2.2.4. By End User
7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Source
7.3.3.2.3. By Function
7.3.3.2.4. By End User
7.3.4. Italy Pharmaceutical Gelatin Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Source
7.3.4.2.3. By Function
7.3.4.2.4. By End User
7.3.5. Spain Pharmaceutical Gelatin Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Source
7.3.5.2.3. By Function
7.3.5.2.4. By End User

8. Asia-Pacific Pharmaceutical Gelatin Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Source
8.2.3. By Function
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pharmaceutical Gelatin Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Source
8.3.1.2.3. By Function
8.3.1.2.4. By End User
8.3.2. India Pharmaceutical Gelatin Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Source
8.3.2.2.3. By Function
8.3.2.2.4. By End User
8.3.3. South Korea Pharmaceutical Gelatin Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Source
8.3.3.2.3. By Function
8.3.3.2.4. By End User
8.3.4. Japan Pharmaceutical Gelatin Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Source
8.3.4.2.3. By Function
8.3.4.2.4. By End User
8.3.5. Australia Pharmaceutical Gelatin Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Source
8.3.5.2.3. By Function
8.3.5.2.4. By End User

9. South America Pharmaceutical Gelatin Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Source
9.2.3. By Function
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pharmaceutical Gelatin Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Source
9.3.1.2.3. By Function
9.3.1.2.4. By End User
9.3.2. Argentina Pharmaceutical Gelatin Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Source
9.3.2.2.3. By Function
9.3.2.2.4. By End User
9.3.3. Colombia Pharmaceutical Gelatin Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Source
9.3.3.2.3. By Function
9.3.3.2.4. By End User

10. Middle East and Africa Pharmaceutical Gelatin Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Source
10.2.3. By Function
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pharmaceutical Gelatin Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Source
10.3.1.2.3. By Function
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Pharmaceutical Gelatin Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Source
10.3.2.2.3. By Function
10.3.2.2.4. By End User
10.3.3. UAE Pharmaceutical Gelatin Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Source
10.3.3.2.3. By Function
10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Gelita AG
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Trobas Pharmaceutical gelatine B.V
14.3. Rousselot SAS
14.4. Gelatines Weishardt SAS
14.5. Sterling Biotec Ltd.
14.6. Catalent, Inc
14.7. Nitta Pharmaceutical Gelatin India Limited
14.8. Aspire Pharmaceuticals
14.9. Gelco International
14.10. Lapi Gelatine S.p.a

15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

Gelita AG
Trobas Pharmaceutical gelatine B.V
Rousselot SAS
Gelatines Weishardt SAS
Sterling Biotec Ltd.
Catalent, Inc
Nitta Pharmaceutical Gelatin India Limited
Aspire Pharmaceuticals
Gelco International
Lapi Gelatine S.p.a

Table Information

Report Attribute	Details
No. of Pages	181
Published	April 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.89 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.61 Billion
Compound Annual Growth Rate	5.5%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4121EUR$4,500USD£3,511GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5037EUR$5,500USD£4,291GBP